Literature DB >> 28324501

Assessing Telomerase Activities in Mammalian Cells Using the Quantitative PCR-Based Telomeric Repeat Amplification Protocol (qTRAP).

Shuai Jiang1, Mengfan Tang2, Huawei Xin3, Junjiu Huang4.   

Abstract

Telomerase expression and activity appear elevated in >80% of human cancers. The activity of the telomerase may serve as a diagnostic marker for malignancy, and an indicator of the proliferative potential of somatic and stem cells. The telomeric repeat amplification protocol (TRAP) is a sensitive and accurate PCR-based assay for telomerase detection and measurement. Here, we describe a quantitative PCR-based TRAP assay (qTRAP) that is more convenient and amenable to high-throughput applications compared to traditional gel-based TRAP assays. qTRAP can not only facilitate drug screening processes for compounds that regulate telomerase activities but also enable the measurement of total telomerase activities of cultured cells or clinical specimens; the latter should prove particularly valuable to investigators of malignancies and diseases that are associated with telomerase and telomere dysfunction.

Entities:  

Keywords:  PCR; TERT; Telomerase; Telomere; qTRAP

Mesh:

Substances:

Year:  2017        PMID: 28324501     DOI: 10.1007/978-1-4939-6892-3_9

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  2 in total

1.  Characterization of Allele-Specific Regulation of Telomerase Reverse Transcriptase in Promoter Mutant Thyroid Cancer Cell Lines.

Authors:  Brittany A McKelvey; Timothy Gilpatrick; Yongchun Wang; Winston Timp; Christopher B Umbricht; Martha A Zeiger
Journal:  Thyroid       Date:  2020-05-04       Impact factor: 6.568

2.  An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase.

Authors:  Zhifen Zhou; Yujing Li; Huimin Xu; Xiaowei Xie; Zibin He; Song Lin; Ruofei Li; Shouheng Jin; Jun Cui; Hai Hu; Feng Liu; Su Wu; Wenbin Ma; Zhou Songyang
Journal:  iScience       Date:  2022-01-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.